Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 5/20 | 0.68 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.68 |
| ▸ | THRA | P10827 | 3/20 | 0.66 |
| ▸ | THRB | P10828 | 3/20 | 0.66 |
| ▸ | ESR1 | P03372 | 1/20 | 0.66 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.66 |
| ▸ | PGR | P06401 | 1/20 | 0.66 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.66 |
| ▸ | AR | P10275 | 1/20 | 0.66 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.61 |
| ▸ | PTPRB | P23467 | 1/20 | 0.57 |
| ▸ | CDC25A | P30304 | 1/20 | 0.57 |
| ▸ | CDC25B | P30305 | 1/20 | 0.57 |
| ▸ | PTEN | P60484 | 1/20 | 0.57 |
| ▸ | PTPMT1 | Q8WUK0 | 1/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.55 |
| ▸ | PPARD | Q03181 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL27484825 | 0.92 | FFAR1 (0.59) | FFAR1FFAR4THRATHRBESR1 | |
| SCHEMBL1445967 | 0.89 | HDAC3 (0.63) | FFAR1FFAR4THRATHRBESR1 | |
| SCHEMBL29676744 | 0.87 | MAPT (0.62) | FFAR1FFAR4THRATHRBESR1 | |
| SCHEMBL2067295 | 0.87 | MAPT (0.62) | FFAR1FFAR4THRATHRBESR1 | |
| SCHEMBL7332798 | 0.86 | TAAR1 (0.57) | FFAR1FFAR4THRATHRBESR1 | |
| SCHEMBL2066307 | 0.86 | MAPT (0.66) | FFAR1FFAR4THRATHRBESR1 | |
| SCHEMBL28210558 | 0.86 | FFAR1 (0.57) | FFAR1FFAR4THRATHRBESR1 | |
| SCHEMBL70271 | 0.86 | KEAP1 (0.74) | FFAR1FFAR4KEAP1PTPRBCDC25A | |
| Acetic Acid SCHEMBL27594133 | 0.84 | HDAC3 (0.58) | FFAR1FFAR4THRATHRBESR1 | |
| Phenyl Propionic Acid SCHEMBL28549085 | 0.84 | FFAR1 (0.59) | FFAR1FFAR4THRATHRBESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 466 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3478652-B1 | ORGANIC LIGAND AND PREPARATION METHOD THEREOF, QUANTUM DOT STRUCTURE MATERIAL, QUANTUM-DOT-CONTAINING LAYER, AND LIGHT EMITTING DIODE | BOE TECHNOLOGY GROUP CO LTD (CN) | 2024-02-07 | — | — | EP | claimed |
| US-20180215695-A1 | ORGANIC LIGAND AND PREPARATION METHOD THEREOF, QUANTUM DOT STRUCTURE MATERIAL, QUANTUM-DOT-CONTAINING LAYER, AND LIGHT EMITTING DIODE | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2018-08-02 | — | — | US | claimed |
| CN-1201454-A | Meta-guanidino, ureido, thioureido or azacyclic aminobenzoic acid derivatives as integrin antagonists | SEARLE & CO (US) | 1998-12-09 | — | — | CN | claimed |
| US-20260034127-A1 | TREATMENT OF GVHD | KADMON CORP LLC (FR) | 2026-02-05 | — | — | US | disclosed |
| US-12509446-B2 | FYN and VEGFR2 kinase inhibitors | ROTTAPHARM BIOTECH S.R.L. (IT) | 2025-12-30 | — | — | US | disclosed |
| CN-119894882-A | Tertiary amine compound, preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| WO-2025085560-A1 | LYSINE ACETYLTRANSFERASE INHIBITORS | Kronos Bio, Inc. (US) | 2025-04-24 | — | — | WO | disclosed |
| US-20250027130-A1 | Nucleic Acid Synthesis and Sequencing Using Tethered Nucleoside Triphosphates | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-23 | — | — | US | disclosed |
| CN-113631168-B | GPR35 modulators | 普罗米修斯生物科学公司 | 2024-11-19 | — | — | CN | disclosed |
| CN-115279747-B | FYN and VEGFR2 kinase inhibitors | 罗达制药生物技术有限责任公司 | 2024-11-05 | — | — | CN | disclosed |
| WO-2024217537-A1 | TERTIARY AMINE COMPOUND AS WELL AS PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 深圳信立泰药业股份有限公司 | 2024-10-24 | — | — | WO | disclosed |
| US-20040010019-A1 | Aromatic sulfone hydroxamates and their use as protease inhibitors | PHARMACIA CORPORATION | 2004-01-15 | — | — | US | disclosed |
| WO-2003084959-A1 | THIOPENE-BASED TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-10-16 | — | — | WO | disclosed |
| WO-2002092588-A2 | AROMATIC SULFONE HYDROXAMATES AND THEIR USE AS PROTEASE INHIBITORS | PHARMACIA CORPORATION (US) | 2002-11-21 | — | — | WO | disclosed |
| CN-1266054-A | Aryl carboxylic acid and tetrazole derivant | HOFFMANN LA ROCHE (CH) | 2000-09-13 | — | — | CN | disclosed |
| WO-2000006156-A1 | AMIDE, CARBAMATE, AND UREA DERIVATIVES | ELI LILLY AND COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| EP-0976744-A1 | Amide, carbamate, and urea derivatives having glutamate receptor function potentiating activity | ELI LILLY AND COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |
| US-5827868-A | Prostaglandin analogs | E. R. SQUIBB & SONS, INC. (US) | 1998-10-27 | — | — | US | disclosed |
| EP-0536713-A1 | Oxazole and imidazole derivatives as prostaglandin analogs | E.R. SQUIBB & SONS, INC. (US) | 1993-04-14 | — | — | EP | disclosed |
| US-5180741-A | Insecticides | ROUSSEL UCLAF (FR) | 1993-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180215695-A1 | ORGANIC LIGAND AND PREPARATION METHOD THEREOF, QUANTUM DOT STRUCTURE MATERIAL, QUANTUM-DOT-CONTAINING LAYER, AND LIGHT EMITTING DIODE | L1CAM, NECTIN4, CD2 | FFAR1 4314/4885FFAR4 3765/4885THRA 918/4885 |
| US-12509446-B2 | FYN and VEGFR2 kinase inhibitors | FYN, LCK, LYN | FFAR1 883/4885FFAR4 1594/4885THRA 2131/4885 |
| US-20260034127-A1 | TREATMENT OF GVHD | ROCK2, RHOA, MYH2 | FFAR1 4702/4885FFAR4 4437/4885THRA 4393/4885 |
| US-20040010019-A1 | Aromatic sulfone hydroxamates and their use as protease inhibitors | MMP1, MMP3, MMP7 | FFAR1 4625/4885FFAR4 4669/4885THRA 2719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.